Quick Answer
Evofem Biosciences, Inc. reported Long Term Debt of $7.21 million for the year ending 2015.
- Evofem Biosciences, Inc. showed a decrease of -26.0% in Long Term Debt from 2014 to 2015.
- This data is from Evofem Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2017.
- XBRL data for this metric is available from 2014 to 2015 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $9.30 million | Q2 2015: $8.62 million | Q3 2015: $7.92 million | Q1 2016: $3.15 million | Q2 2016: $2.81 million.
- Historical annual values: Fiscal year 2015: $7.21 million | Fiscal year 2014: $9.74 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: